MwanzoAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$ 0.22
Kabla ya soko:(0.51%)-0.0011
$ 0.21
Imefungwa: 13 Jan, 09:00:20 GMT -5 · USD · NYSEAMERICAN · Kanusho
Bei iliyotangulia
$ 0.22
Bei za siku
$ 0.21 - $ 0.21
Bei za mwaka
$ 0.16 - $ 0.62
Thamani ya kampuni katika soko
13.53M USD
Wastani wa hisa zilizouzwa
elfu 531.56
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 35.00 | -23.91% |
Matumizi ya uendeshaji wa biashara | 4.52M | -44.74% |
Mapato halisi | -3.70M | 52.66% |
Kiwango cha faida halisi | elfu -10.57 | 37.78% |
Mapato kwa kila hisa | -0.07 | 57.39% |
EBITDA | -4.43M | 45.38% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 7.20M | -67.89% |
Jumla ya mali | 13.59M | -51.23% |
Jumla ya dhima | 10.68M | 103.00% |
Jumla ya hisa | 2.91M | — |
hisa zilizosalia | 63.71M | — |
Uwiano wa bei na thamani | 4.30 | — |
Faida inayotokana na mali | -76.60% | — |
Faida inayotokana mtaji | -142.29% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -3.70M | 52.66% |
Pesa kutokana na shughuli | -3.11M | 45.16% |
Pesa kutokana na uwekezaji | elfu 334.00 | 199.40% |
Pesa kutokana na ufadhili | elfu 137.00 | -41.20% |
Mabadiliko halisi ya pesa taslimu | -2.64M | 54.30% |
Mtiririko huru wa pesa | -2.11M | 34.80% |
Kuhusu
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Ilianzishwa
1966
Makao Makuu
Tovuti
Wafanyakazi
27
